Iron reduction and sustained response to interferon-α therapy in patients with chronic hepatitis C: results of an Italian multicenter randomized study
暂无分享,去创建一个
M. Massari | R. Ceriani | M. Mattioli | B. Cesana | O. Riggio | S. Fargion | G. Belloni | A. Fracanzani | F. Bissoli | G. Fiorelli | M. Ballaré | M. Borzio | A. Rossini | L. Morini | A. Orlandi | S. Oldani | C. Trischitta | P. Fiore
[1] H. Bonkovsky,et al. Iron reduction as an adjuvant to interferon therapy in patients with chronic hepatitis C who have previously not responded to interferon: A multicenter, prospective, randomized, controlled trial , 2000, Hepatology.
[2] R. Levine,et al. Iron reduction before and during interferon therapy of chronic hepatitis C: Results of a multicenter, randomized, controlled trial , 2000, Hepatology.
[3] G. Davis,et al. Increased hepatic iron deposition resulting from treatment of chronic hepatitis C with ribavirin. , 2000, American journal of clinical pathology.
[4] William M. Lee,et al. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group. , 1998, The New England journal of medicine.
[5] J. Hoefs,et al. Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group. , 1998, The New England journal of medicine.
[6] J. Grove,et al. Heterozygosity for hereditary hemochromatosis is associated with more fibrosis in chronic hepatitis C , 1998, Hepatology.
[7] Fiedler,et al. Liver biopsy is a useful predictor of response to interferon therapy in chronic hepatitis C , 1998, Histopathology.
[8] M. Mizokami,et al. A pilot randomized, controlled trial of the effect of iron depletion on long-term response to α-interferon in patients with chronic hepatitis C , 1998 .
[9] M. Mattioli,et al. High prevalence of the His63Asp HFE mutation in italian patients with porphyria cutanea tarda , 1998, Hepatology.
[10] A. Sangchan. Interferon Alfa-2b Alone or in Combination with Ribavin as Intial Treatment for Chronic Hepatitis C , 1998 .
[11] M. Mizokami,et al. A pilot randomized, controlled trial of the effect of iron depletion on long-term response to alpha-interferon in patients with chronic hepatitis C. , 1998, Journal of hepatology.
[12] G. Davis,et al. Factors predictive of a beneficial response to therapy of hepatitis C , 1997, Hepatology.
[13] E. Zuckerman,et al. Effect of iron depletion on long-term response to interferon-alpha in patients with chronic hepatitis C who previously did not respond to interferon therapy. , 1997, The American journal of gastroenterology.
[14] M. Mattioli,et al. Liver iron influences the response to interferon alpha therapy in chronic hepatitis C , 1997, European journal of gastroenterology & hepatology.
[15] A. Rothman,et al. Iron and chronic viral hepatitis , 1997, Hepatology.
[16] S. Fargion,et al. Iron stores, response to alpha-interferon therapy, and effects of iron depletion in chronic hepatitis C. , 2008, Liver.
[17] R. Kirsch,et al. Threshold effect of liver iron content on hepatic inflammation and fibrosis in hepatitis B and C. , 1996, Journal of hepatology.
[18] A. Gasbarrini,et al. Retreatment of hepatitis C interferon non-responders with larger doses of interferon with and without phlebotomy. , 1996, Hepato-gastroenterology.
[19] M. Sakurai,et al. Relationship between hepatic iron deposits and response to interferon in chronic hepatitis C. , 1996, The American journal of gastroenterology.
[20] N. Terrault,et al. Interferon and hepatitis C. , 1995, The New England journal of medicine.
[21] M. Tong,et al. Clinical outcomes after transfusion-associated hepatitis C. , 1995, The New England journal of medicine.
[22] H. Bonkovsky,et al. Distribution of iron in the liver predicts the response of chronic hepatitis C infection to interferon therapy. , 1995, American journal of clinical pathology.
[23] E. Schiff,et al. Hepatic iron concentration as a predictor of response to interferon alfa therapy in chronic hepatitis C. , 1995, Gastroenterology.
[24] M. Yano,et al. Improvement of serum aminotransferase levels after phlebotomy in patients with chronic active hepatitis C and excess hepatic iron. , 1994, The American journal of gastroenterology.
[25] P. Marcellin,et al. Treatment of chronic viral hepatitis. , 1994, Bailliere's clinical gastroenterology.
[26] W. Irish,et al. Response to interferon α therapy is influenced by the iron content of the liver , 1994 .
[27] J. Hoofnagle,et al. Increase in hepatic iron stores following prolonged therapy with ribavirin in patients with chronic hepatitis C. , 1994, Journal of hepatology.
[28] Motohiro Shibata,et al. Detection of hepatitis C virus by polymerase chain reaction and response to interferon‐α therapy: Relationship to genotypes of hepatitis C virus , 1992, Hepatology.
[29] D. Hosmer,et al. Applied Logistic Regression , 1991 .
[30] Mark L. Bassett,et al. Value of hepatic iron measurements in early hemochromatosis and determination of the critical iron level associated with fibrosis , 1986, Hepatology.
[31] Neil Kaplowitz,et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis , 1981, Hepatology.
[32] S. Sherlock,et al. Measurement of liver-iron concentration in needle-biopsy specimens. , 1971, Lancet.